MedTrace Logo

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

NCT03811288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7548

Last updated 2020-06-09

No results posted yet for this study

Summary

The purpose of the study is to register the occurrence of cardiovascular disease among type 2 diabetes patients across ten countries across the world. Participants will be asked to give information about their health. Participants will continue their normal way of life and will not get any medication other than prescribed to them by their doctor. Participants' participation will be one day/one visit at their doctor. The study will last for about 6 months in total.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

No treatment given

No specific intervention is studied. All anti-diabetic and CV medication will be prescribed at the physician's discretion under routine clinical practice conditions.

Sponsors & Collaborators

Principal Investigators

  • Clinical Reporting Anchor and Disclosure (1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-10
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Algeria
  • Argentina
  • Australia
  • Brazil
  • China
  • Israel
  • Japan
  • Mexico
  • Saudi Arabia
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03811288 on ClinicalTrials.gov